Pediatric surgery international · 2025
The application of stay sutures in thoracoscopic esophageal repair for Type C esophageal atresia.
СтатьяРандомизированное исследованиеНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Zhu Shichun, Liu Zhenyong, Li Bing
Аннотация
PURPOSE: To investigate the clinical application of stay sutures in thoracoscopic repair for esophageal atresia (EA) combined with tracheoesophageal fistula (TEF).
METHODS: A total of 56 neonates diagnosed with Type C EA received thoracoscopic correction surgery from May 2019 to December 2024. The patients were divided into 2 groups randomly: (1) Esophageal anastomosis was constructed using interrupted sutures on the posterior wall and continuous locked stitches on the anterior wall assisted by two stay sutures (Group A; n = 30) and (2) Esophageal anastomosis was performed using traditional techniques with interrupted sutures on both anterior and posterior walls (Group B; n = 26). A comprehensive comparison of operative parameters and postoperative complications was systematically conducted between the two surgical methods.
RESULTS: The mean anastomotic time was significantly shorter in Group A (20.5 ± 3.3 min) compared with Group B (41.0 ± 4.5 min, P < 0.05). Similarly, operation time was 126.5 ± 15.5 min in Group A versus 154.5 ± 13.5 min in Group B (P < 0.05). Postoperative ventilator support duration was 2.1 ± 0.7 days in Group A versus 2.3 ± 0.6 days in Group B (P > 0.05). The time to first oral intake was 8.5 ± 1.8 days in Group A versus 9.3 ± 3.2 days in Group B (P > 0.05). An upper gastrointestinal series performed on postoperative day 5-7 revealed anastomotic leakage in 4 of 30 patients (13.3%) in Group A versus 6 of 26 patients (23.1%) in Group B (P > 0.05). Anastomotic stenosis was observed in 6 patients (20%) in Group A and 6 patients (23.1%) in Group B postoperatively, also with no statistically significant difference between the groups (P > 0.05). No recurrence of TEF was observed in each group.
CONCLUSION: This innovative approach significantly shortens the operative time in the thoracoscopic treatment of Type C EA.
METHODS: A total of 56 neonates diagnosed with Type C EA received thoracoscopic correction surgery from May 2019 to December 2024. The patients were divided into 2 groups randomly: (1) Esophageal anastomosis was constructed using interrupted sutures on the posterior wall and continuous locked stitches on the anterior wall assisted by two stay sutures (Group A; n = 30) and (2) Esophageal anastomosis was performed using traditional techniques with interrupted sutures on both anterior and posterior walls (Group B; n = 26). A comprehensive comparison of operative parameters and postoperative complications was systematically conducted between the two surgical methods.
RESULTS: The mean anastomotic time was significantly shorter in Group A (20.5 ± 3.3 min) compared with Group B (41.0 ± 4.5 min, P < 0.05). Similarly, operation time was 126.5 ± 15.5 min in Group A versus 154.5 ± 13.5 min in Group B (P < 0.05). Postoperative ventilator support duration was 2.1 ± 0.7 days in Group A versus 2.3 ± 0.6 days in Group B (P > 0.05). The time to first oral intake was 8.5 ± 1.8 days in Group A versus 9.3 ± 3.2 days in Group B (P > 0.05). An upper gastrointestinal series performed on postoperative day 5-7 revealed anastomotic leakage in 4 of 30 patients (13.3%) in Group A versus 6 of 26 patients (23.1%) in Group B (P > 0.05). Anastomotic stenosis was observed in 6 patients (20%) in Group A and 6 patients (23.1%) in Group B postoperatively, also with no statistically significant difference between the groups (P > 0.05). No recurrence of TEF was observed in each group.
CONCLUSION: This innovative approach significantly shortens the operative time in the thoracoscopic treatment of Type C EA.